Michael Zasloff
Direttore/Membro del Consiglio presso AMPHASTAR PHARMACEUTICALS, INC.
Patrimonio netto: 870 741 $ in data 30/04/2024
Posizioni attive di Michael Zasloff
Società | Posizione | Inizio | Fine |
---|---|---|---|
AMPHASTAR PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/10/2005 | - |
Independent Dir/Board Member | 01/10/2005 | - | |
Georgetown University School of Medicine | Corporate Officer/Principal | 01/01/2002 | - |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Direttore/Membro del Consiglio | - | - |
Direttore Tecnico/Scientifico/R&S | 01/01/2016 | - | |
Fondatore | 01/01/2016 | - | |
Amministratore Delegato | 01/01/2016 | 16/10/2020 | |
Presidente | 01/01/2016 | - | |
Formula XO, Inc.
Formula XO, Inc. Household/Personal CareConsumer Non-Durables Formula XO, Inc. manufactures beauty solutions. It develops, manufactures and distributes the illumai Biome Care System for the hair– the only hair system on the market made to protect, nurture and maintain the biome of the hair, skin and scalp. The company was founded by Wayne Willis, Mario Russo and Michael Zasloff in 2013 and is headquartered in Sterling, VA. | Direttore/Membro del Consiglio | 01/01/2013 | - |
Direttore Tecnico/Scientifico/R&S | 01/01/2013 | - | |
Fondatore | 01/01/2013 | - |
Storia della carriera di Michael Zasloff
Precedenti posizioni note di Michael Zasloff
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ferris, Baker Watts, Inc.
Ferris, Baker Watts, Inc. Investment Banks/BrokersFinance Ferris, Baker Watts, Inc. is a full-service investment banking firm with expertise in mergers and acquisitions, debt and equity underwritings, and other investment banking functions. They are headquartered in Washington, DC with additional offices in Baltimore, Richmond and San Francisco. They are a member of the NYSE and SIPC, and are wholly-owned by their employees. They serve clients throughout the mid-Atlantic region | Analyst-Equity | 01/01/2004 | 01/01/2007 |
Corporate Officer/Principal | 01/01/2004 | 01/01/2007 | |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Direttore/Membro del Consiglio | 01/01/1992 | 01/01/2001 |
Fondatore | 01/01/1992 | 01/01/2001 | |
Corporate Officer/Principal | 01/01/1992 | 01/01/2001 | |
Perelman School of Medicine | Corporate Officer/Principal | 01/01/1988 | 01/01/1992 |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 01/01/1988 | 01/01/1992 |
University of Pennsylvania Medical Center | Corporate Officer/Principal | 01/01/1988 | 01/01/1992 |
░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Michael Zasloff
Columbia College (California) | Undergraduate Degree |
New York University School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Posizioni
Corporate Officer/Principal | 7 |
Director/Board Member | 4 |
Founder | 3 |
Settori
Consumer Services | 6 |
Health Technology | 4 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
AMPHASTAR PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 6 |
---|---|
Ferris, Baker Watts, Inc.
Ferris, Baker Watts, Inc. Investment Banks/BrokersFinance Ferris, Baker Watts, Inc. is a full-service investment banking firm with expertise in mergers and acquisitions, debt and equity underwritings, and other investment banking functions. They are headquartered in Washington, DC with additional offices in Baltimore, Richmond and San Francisco. They are a member of the NYSE and SIPC, and are wholly-owned by their employees. They serve clients throughout the mid-Atlantic region | Finance |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | Health Technology |
National Institutes of Health
National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services The Children's Hospital of Philadelphia provides health care services. It specializes in pediatrics, research, fetal surgery, pediatric oncology, pediatric cardiology and cardiothoracic surgery, thoracic insufficiency syndrome, and pediatric airway disorders and transplants. The company was founded by Francis West Lewis in 1855 and is headquartered in Philadelphia, PA. | Health Services |
Enterin, Inc.
Enterin, Inc. BiotechnologyHealth Technology Enterin, Inc. develops novel compounds that dysfunctional gut-brain axis in patients with neurodegenerative disease. The company was founded by Denise Barbut, Michael A. Zasloff, and William A. Kinney and is headquartered in Philadelphia, PA. | Health Technology |
Formula XO, Inc.
Formula XO, Inc. Household/Personal CareConsumer Non-Durables Formula XO, Inc. manufactures beauty solutions. It develops, manufactures and distributes the illumai Biome Care System for the hair– the only hair system on the market made to protect, nurture and maintain the biome of the hair, skin and scalp. The company was founded by Wayne Willis, Mario Russo and Michael Zasloff in 2013 and is headquartered in Sterling, VA. | Consumer Non-Durables |
- Borsa valori
- Insiders
- Michael Zasloff
- Esperienza